Clinical treatment and management of invasive fungal disease in recipients of solid organ transplantation / 器官移植
Organ Transplantation
; (6): 151-159, 2024.
Article
в Zh
| WPRIM
| ID: wpr-1005246
Ответственная библиотека:
WPRO
ABSTRACT
With widespread application of solid organ transplantation (SOT), the incidence of postoperative invasive fungal disease (IFD) in SOT recipients has been increased year by year. In recent years, the awareness of preventive antifungal therapy for SOT recipients has been gradually strengthened. However, the problem of fungal resistance has also emerged, leading to unsatisfactory efficacy of original standardized antifungal regimens. Drug-drug interaction and hepatorenal toxicity induced by drugs are also challenges facing clinicians. In this article, the characteristics of drug-drug interaction and hepatorenal toxicity among triazole, echinocandin and polyene antifungal drugs and immunosuppressants were reviewed, and postoperative preventive strategies for IFD in different types of SOT recipients and treatment strategies for IFD caused by infection of different pathogens were summarized, aiming to provide reference for physicians in organ transplantation and related disciplines.
Полный текст:
1
База данных:
WPRIM
Язык:
Zh
Журнал:
Organ Transplantation
Год:
2024
Тип:
Article